Audit Reports
Prostate Cancer
MCN for Urological Cancers – Report of the Prostate QPI Clinical Audit Data 2022/23
MCN for Urological Cancers – Report of the Prostate QPI Clinical Audit Data 2021/22
MCN for Urological Cancers – Report of the Prostate QPI Clinical Audit Data 2020/21
Renal Cancer
MCN for Urological Cancers – Report of the Renal QPI Clinical Audit Data 2023
MCN for Urological Cancers – Report of the Renal QPI Clinical Audit Data 2022
MCN for Urological Cancers – Report of the Renal QPI Clinical Audit Data 2021
Testicular Cancer
MCN for Urological Cancers – Report of the Testicular Cancer QPI Audit Data 2022/23
MCN for Urological Cancers – Report of the Testicular Cancer QPI Audit Data 2021/22
MCN for Urological Cancers – Report of the Testicular Cancer QPI Audit Data 2020/21
Bladder Cancer
MCN for Urological Cancers – Report of the Bladder QPI Clinical Audit Data 2022/23
MCN for Urological Cancers – Report of the Bladder QPI Clinical Audit Data 2020/21
MCN for Urological Cancers – Report of the Bladder QPI Clinical Audit Data 2019/20
Renal Pelvis and Ureter (RPU) Cancer
MCN for Urological Cancers – Report of the RPU Clinical Audit Data 2018
MCN for Urological Cancers – Report of the RPU Clinical Audit Data 2017
MCN for Urological Cancers – Report of the RPU Clinical Audit Data 2016
| Follow up Guidelines | Issue Date | Review Date |
|
November 2015
|
under review | |
| Prostate Cancer Regional Digital Follow-up (DFUP) Guidance v2.0 | April 2025 |
November 2027
|
|
December 2023
|
December 2026
|
|
| Solid Renal Lesions Identified on US CGD V1.1 |
January 2025
|
December 2028
|
| Testicular Cancer Follow-up Guideline V6.0 | December 2024 | March 2027 |
Robotic Assisted Laparascopic Prostatectomy: Patient Information
| Review Date | ||
| May 2025 | ||
| May 2025 |